<DOC>
	<DOCNO>NCT00753116</DOCNO>
	<brief_summary>The purpose study investigate clinical utility renal denervation treatment ESRD patient refractory hypertension .</brief_summary>
	<brief_title>Renal Denervation End Stage Renal Disease Patients With Refractory Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Systolic blood pressure 160 mmHg great On 3 antihypertensive medication On dialysis 6 month Renal artery abnormality Known secondary hypertension attributable cause sleep apnea MI , angina , CVA within 6 month Others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>